Searched for
ANTIBIOTIC RESISTANCE IN INDIA
Stress, poor sleep and processed food are driving heart attacks in young Indians: Ramakanta PandaYoung Indian professionals, particularly in IT and finance, are facing a heart disease crisis due to unhealthy lifestyles. Leading cardiac ...- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...
- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
- Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibioticWockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...
- Wockhardt gets CDSCO nod for Zaynich antibioticWockhardt Ltd has secured approval from the CDSCO for its new antibiotic, Zaynich. This drug is developed in India and will be used to trea...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Delhi’s RML Hospital ortho surgeon warns India is sleepwalking into an antibiotic disaster fueled by a medicine 'eaten more than toffee or roti'A New Delhi based orthopaedic and sports surgeon has issued a stark warning about India’s growing antibiotic resistance crisis. In an Insta...
- FSSAI sets stricter rule for antibiotics in food items"If enforced strictly, the regulations will ensure safer food products for consumers by setting stricter residue and contaminant limits acr...
- Antibiotics becoming ineffective against diseases like typhoid, pneumonia, and urinary infections: ICMR rings alarmA recent ICMR report highlights a troubling rise in antibiotic resistance in India. Diseases like UTIs, blood infections, pneumonia, and ty...
- Can Kerala's antibiotic abuse project inspire India's antimicrobial resistance fight?In 2019, nearly 300,000 deaths in India were due to AMR. Over 1 million deaths were linked to drug resistance, making infections more chall...
- Superbug-related death spurs drug regulator warningThe Centre has also asked state drug regulators to take "strong policy measures including stringent regulatory action on the over-the-count...
- India's antibiotics usage witnessed maximum rise among LMICs in 15 years: StudyDoctors and experts have warned that with the prolonged use of antibiotics, many patients have become anti-antibiotic that even the primary...
- Growing drug resistance: Antibiotic consumption in India has skyrocketed, finds new studyAntibiotic consumption in India increased 103% between 2000 and 2015—the highest in low and middle-income countries, according to the study.
- WHO highlights misunderstanding about antibiotic resistance in IndiaAround 75 per cent of Indians who took part in a WHO survey think, incorrectly, that colds and flu can be treated with antibiotics, the UN ...
- ‘Antibiotic addict’ India losing fight against lethal bacteriaThe report confirms the findings of a Princeton University study in 2014 which said Indians consume the highest number of antibiotics in th...
Load More
